Decreased delta sleep ratio and elevated alpha power predict vulnerability to depression during interferon-alpha treatment

Acta Neuropsychiatrica

Volumn 27, Issue 1, 2014, Pages 14-24

  Lotrich, Francis E ^a   Germain, Anne ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

depression; EEG; HCV; hepatitis; psychoneuroimmunology; sleep

Indexed keywords

ALPHA INTERFERON;

ADULT; ALCOHOL ABUSE; ALPHA POWER; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL ARTICLE; DELTA SLEEP RATIO; DEPRESSION; DISEASE COURSE; ELECTROENCEPHALOGRAM; FEMALE; HEPATITIS C; HUMAN; MALE; MEDICAL HISTORY; PANIC; POLYSOMNOGRAPHY; POSTTRAUMATIC STRESS DISORDER; REM SLEEP; REMISSION; SELF REPORT; SLEEP DEPRIVATION; SLEEP PARAMETERS; SLEEP QUALITY; SLEEP STAGE; SLEEP TIME; SLOW WAVE SLEEP; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; CHEMICALLY INDUCED; COMPLICATION; DRUG EFFECTS; HEPATITIS C, CHRONIC; MIDDLE AGED; PREDICTIVE VALUE; PROSPECTIVE STUDY; PSYCHOLOGY;

BRAIN WAVES; DEPRESSION; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SLEEP STAGES;

EID: 84922709885     PISSN: 09242708     EISSN: 16015215     Source Type: Journal    
DOI: 10.1017/neu.2014.30     Document Type: Article

References (111)

1. PATTEN SB. Long-term medical conditions and major depression in a Canadian population study at waves 1 and 2. J Affective Disord 2001;63:35-41.
2. EATON WW, KRAMER M, ANTHONY JC, DRYMAN A, SHAPIRO S, LOCKE BZ. The incidence of specific DIS/DSM-III mental disorders: data from the NIMH Epidemiologic Catchment Area Program. Acta Psychiatr Scand 1989;79:163-178.
3. PATTEN SB, LEE RC. Refining estimates of major depression incidence and episode duration in Canada using a Monte Carlo Markov model. Med Decis Making 2004;24:351-358.
4. KRUIJT A-W, ANTYPA N, BOOIJ L et al. Cognitive reactivity, implicit associations, and the incidence of depression: a two-year prospective study. PLoS One 2013;8:e70245.
5. BOYES AW, GIRGIS A, D'ESTE CA, ZUCCA AC, LECATHELINAIS C, CAREY ML. Prevalence and predictors of the short-term trajectory of anxiety and depression in the first year after a cancer diagnosis: a population-based longitudinal study. J Clin Oncol 2013;31:2724-2729.
6. UDINA M, CASTELLVI P, MORENO-ESPANA J et al. Interferoninduced depression in chronic hepatitis C: a systematic review and meta-analysis. J Clin Psychiatry 2012;73:1128-1138.
7. BRESLAU N, ROTH T, ROSENTHAL L, ANDRESKI P. Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults. Biol Psychiatry 1996;39:411-418.
8. GREGORY AM, RIJSDIJK FV, LAU JY et al. The direction of longitudinal associations between sleep problems and depression symptoms: a study of twins aged 8 and 10 years. Sleep 2009;32:189-199.
9. BUYSSE DJ, ANGST J, GAMMA A, AJDACIC V, EICH D, ROSSLER W. Prevalence, course, and comorbidity of insomnia and depression in young adults. Sleep 2008;31:473-480.
10. ROANE BM, TAYLOR DJ. Adolescent insomnia as a risk factor for early adult depression and substance abuse. Sleep 2008;31:1351-1356.
11. EMSLIE GJ, ARMITAGE R, WEINBERG WA, RUSH AJ, MAYES TL, HOFFMANN RF. Sleep polysomnography as a predictor of recurrence in children and adolescents with major depressive disorder. Int J Neuropsychopharmacol 2001;4:159-168.
12. BUYSSE DJ, HALL M, TU XM et al. Latent structure of EEG sleep variables in depressed and control subjects: descriptions and clinical correlates. Psychiatry Res 1998;79:105-122.
13. ARMITAGE R, HOFFMANN R, TRIVEDI M, RUSH AJ. Slow-wave activity in NREM sleep: sex and age effects in depressed outpatients and healthy controls. Psychiatry Res 2000;95:201-213.
14. STEIGER A, KIMURA M. Wake and sleep EEG provide biomarkers in depression. J Psychiatr Res 2010;44:242-252.
15. KUPFER DJ, FRANK E, EHLERS CL. EEG sleep in young depressives: first and second night effects. Biol Psychiatry 1989;25:87-97.
16. KUPFER DJ, FRANK E, MCEACHRAN AB, GROCHOCINSKI VJ. Delta sleep ratio. A biological correlate of early recurrence in unipolar affective disorder. Arch Gen Psychiatry 1990;47:1100-1105.
17. WICHNIAK A, WIERZBICKA A, JERNAJCZYK W. Sleep and antidepressant treatment. Curr Pharm Des 2012;18:5808-5817.
18. FELGER JC, LOTRICH FE. Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications. Neuroscience 2013;246:199-229.
19. FRANZEN PL, BUYSSE DJ, RABINOVITZ M, POLLOCK BG, LOTRICH FE. Poor sleep quality predicts onset of either major depression or subsyndromal depression with irritability during interferon-alpha treatment. J Psychiatr Res2009;177:240-245.
20. PRATHER A, RABINVITZ M, POLLOCK B, LOTRICH F. Cytokineinduced depression during IFN-a treatment: the role of IL-6 and sleep quality. Brain Behav Immunol 2009;23:1109-1116.
21. CAMPBELL IG, DARCHIA N, HIGGINS LM et al. Adolescent changes in homeostatic regulation of EEG activity in the delta and theta frequency bands during NREM sleep. Sleep 2011;34:83-91.
22. CSERCSA R, DOMBOVARI B, FABO D et al. Laminar analysis of slow wave activity in humans. Brain 2010;133:2814-2829.
23. DWORAK M, MCCARLEY RW, KIM T, KALINCHUK AV, BASHEER R. Sleep and brain energy levels: ATP changes during sleep. J Neurosci Res 2010;30:9007-9016.
24. MURPHY M, RIEDNER BA, HUBER R, MASSIMINI M, FERRARELLI F, TONONI G. Source modeling sleep slow waves. PNAS USA 2009;106:1608-1613.
25. DANG-VU TT, DESSEILLES M, LAUREYS S et al. Cerebral correlates of delta waves during non-REM sleep revisited. Neuroimage 2005;28:14-21.
26. NOFZINGER EA. Neuroimaging of sleep and sleep disorders. Curr Neurol Neurosci Rep 2006;6:149-155.
27. HALL M, THAYER JF, GERMAIN A et al. Psychological stress is associated with heightened physiological arousal during NREM sleep in primary insomnia. Behav Sleep Med 2007;5:178-193.
28. GERMAIN A, NOFZINGER EA, KUPFER DJ, BUYSSE DJ. Neurobiology of non-REM sleep in depression: further evidence for hypofrontality and thalamic dysregulation. Am J Psychiatry 2004;161:1856-1863.
29. KUPFER DJ, REYNOLDS CF, ULRICH RF, GROCHOCINSKI VJ. Comparison of automated REM and slow-wave sleep analyses in young and middle-aged depressed subjects. Biol Psychiatry 1986;21:189-200.
30. SPANIER C, FRANK E, MCEACHRAN AB, GROCHOCINSKI VJ, KUPFER DJ. The prophylaxis of depressive episodes in recurrent depression following discontinuation of drug therapy: integrating psychological and biological factors. Psychol Med 1996;26:461-475.
31. BUYSSE DJ, FRANK E, LOWE KK, CHERRY CR, KUPFER DJ. Electroencephalographic sleep correlates of episode and vulnerability to recurrence in depression. Biol Psychiatry 1997;41:406-418.
32. REYNOLDS CFR, BUYSSE DJ, BRUNNER DP et al. Maintenance nortriptyline effects on electroencephalographic sleep in elderly patients with recurrent major depression: double-blind, placebo- and plasma-level-controlled evaluation. Biol Psychiatry 1997;42:560-567.
33. LAUER CJ, SCHREIBER W, HOLSBOER F, KRIEG JC. In quest of identifying vulnerability markers for psychiatric disorders by all-night polysomnography. Arch Gen Psychiatry 1995;52:145-153.
34. FENZL T, TOUMA C, ROMANOWSKI CP et al. Sleep disturbances in highly stress reactive mice: modeling endophenotypes of major depression. BMC Neurosci 2011;12:29.
35. NITSCHKE JB, HELLER W, ETIENNE MA, MILLER GA. Prefrontal cortex activity differentials processes affecting memory in depression. Biol Psychiatry 2004;67:125-143.
36. VON STEIN A, SARNTHEIN J. Different frequencies for different scales of cortical integration: from local gamma to long range alpha/theta synchronization. Int J Psychophysiol 2000;38:301-313.
37. BJORVATN B, FAGERLAND S, URSIN R. EEG power densities (0.5 -20 Hz) in different sleep-wake stages in rats. Physiol Behav 1998;63:413-417.
38. NOFZINGER EA, PRICE JC, MELTZER CC et al. Towards a neurobiology of dysfunctional arousal in depression: the relationship between beta EEG power and regional cerebral glucose metabolism during NREM sleep. Psychiatry Res 2000;98:71-91.
39. KRYSTAL AD, EDINGER JD. Sleep EEG predictors and correlates of the response to cognitive behavioral therapy for insomnia. Sleep 2010;33:669-677.
40. BASTIEN CH, LEBLANC M, CARRIER J, MORIN CM. Sleep EEG power spectra, insomnia, and chronic use of benzodiazepines. Sleep 2003;26:313-317.
41. FEINBERG I, MALONEY T, CAMPBELL IG. Effects of hypnotics on the sleep EEG of healthy young adults: new data and psychopharmacologic implications. J Psychiatr Res 2000;34:423-438.
42. DUMONT GJ, DE VISSER SJ, COHEN AF, VAN GERVEN JM. Biomarkers for the effects of selective serotonin reuptake inhibitors (SSRIs) in healthy subjects. Br J Clin Pharmacol 2005;59:495-510.
43. SILVESTRI R, PACE-SCHOTT EF, GERSH T, STICKGOLD R, SALZMAN C, HOBSON JA. Effects of fluvoxamine and paroxetine on sleep structure in normal subjects: a homebased Nightcap evaluation during drug administration and withdrawal. J Clin Psychiatry 2001;62:642-652.
44. BRITTON WB, HAYNES PL, FRIDEL KW, BOOTZIN RR. Polysomnographic and subjective profiles of sleep continuity before and after mindfulness-based cognitive therapy in partially remitted depression. Psychosom Med 2010;72:539-548.
45. LUNDAHL J, DEACON S, MAURICE D, STANER L. EEG spectral power density profiles during NREM sleep for gaboxadol and zolpidem in patients with primary insomnia. J Psychopharmacol 2012;26:1081-1087.
46. QUERA-SALVA MA, HAJAK G, PHILIP P et al. Comparison of agomelatine and escitalopram on nighttime sleep and daytime condition and efficacy in major depressive disorder patients. Int Clin Psychopharmacol 2011;26:252-262.
47. FIRST MB, SPITZER RL, WILLIAMS JBW et al. Structured clinical interview for DSM-IV (SCID-1) (users guide and interview) research version. New York: Biometrics Research Department, New York Psychiatric Institute, 1995.
48. BECK A, STEER R, GARBIN M. Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev 1988;8:77-100.
49. BUYSSE DJ, REYNOLDS CF, MONK TH, BERMAN SR, KUPFER DJ. Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatr Res 1989;28:193-213.
50. HAYASHINO Y, YAMAZAKI S, TAKEGAMI M, NAKAYAMA T, SOKEJIMA S, FUKUHARA S. Association between number of comorbid conditions, depression, and sleep quality using the Pittsburgh Sleep Quality Index: results from a populationbased survey. Sleep Med 2010;11:366-371.
51. OWEN DC, PARKER KP, MCGUIRE DB. Comparison of subjective sleep quality in patients with cancer and healthy subjects. Oncol Nurs Forum 1999;26:1649-1651.
52. CARPENTER J, ANDRYKOWSKI MA. Psychometric evaluation of the Pittsburgh Sleep Quality Index. J Psychosom Res 1998;45:5-13.
53. MONK TH, REYNOLDS CF, KUPFER DJ et al. The Pittsburgh Sleep Diary. J Sleep Res 1994;3:111-120.
54. DOMAN J, DETKA C, HOFFMAN T et al. Automating the sleep laboratory: implementation and validation of digital recording and analysis. Int J Biomed Comput 1995;38:277-290.
55. BRUNNER DP, VASKO RC, DETKA CS, MONAHAN JP, REYNOLDS CF, KUPFER DJ. Muscle artifacts in the sleep EEG: automated detection and effect on all-night EEG power spectra. J Sleep Res 1996;5:155-164.
56. LANGE H. EEG spectral analysis in vital depression: ultradian cycles. Biol Psychiatry 1982;17:3-21.
57. MCKINNEY SM, DANG-VU TT, BUXTON OM, SOLET JM, ELLENBOGEN JM. Covert waking brain activity reveals instantaneous sleep depth. PLoS One 2011;6:e17351.
58. DAHL RE, WILLIAMSON DE, BERTOCCI MA, STOLZ MV, RYAN ND, EHLERS CL. Spectral analyses of sleep EEG in depressed offspring of fathers with or without a positive history of alcohol abuse or dependence: a pilot study. Alcohol Alcohol 2003;30:193-200.
59. BUDHIRAJA R, QUAN SF, PUNJABI NM, DRAKE CL, DICKMAN R, FASS R. Power spectral analysis of the sleep electroencephalogram in heartburn patients with or without gastroesophageal reflux disease: a feasibility study. J Clin Gastroenterol 2010;44 :91-96.
60. HARMAN K, PIVIK RT, D'EON JL, WILSON KG, SWENSON JR, MATSUNAGA L. Sleep in depressed and nondepressed participants with chronic low back pain: electroencephalographic and behaviour findings. Sleep 2002;25:775-783.
61. STERIADE M, MCCARLEY R. Brainstem control of wakefulness and sleep. New York: Plenum, 1990.
62. STANER L, CORNETTE F, MAURICE D et al. Sleep microstructure around sleep onset differentiates major depressive insomnia from primary insomnia. J Sleep Res 2003;12:319-330.
63. MERICA H, BLOIS R, GAILLARD JM. Spectral characteristics of sleep EEG in chronic insomnia. Eur J Neurosci 1998;10:1826-1834.
64. LUTHRINGER R, MINOT R, TOUSSAINT M, CALVI-GRIES F, SCHALTENBRAND N, MACHER JP. All-night EEG spectral analysis as a tool for the prediction of clinical response to antidepressant treatment. Biol Psychiatry 1995;38:98-104.
65. LINKOWSKI P. EEG sleep patterns in twins. J Sleep Res 1999;8:11-13.
66. AMBROSIUS U, LIETZENMAIER S, WEHRLE R et al. Heritability of sleep electroencephalogram. Biol Psychiatry 2008;64:344-348.
67. BUCKELMULLER J, LANDOLT HP, STASSEN HH, ACHERMANN P. Trait-like individual differences in the human sleep electroencephalogram. Neuroscience 2006;138:351-356.
68. TUCKER AM, DINGES DF, VAN DONGEN HPA. Trait interindividual differences in the sleep physiology of healthy young adults. J Sleep Res 2007;16:170-180.
69. DATTA S, MACLEAN RR. Neurobiological mechanisms for the regulation of mammalian sleep-wake behavior: reinterpretation of historical evidence and inclusion of contemporary cellular and molecular evidence. Neurosci Biobehav Rev 2007;31:775-824.
70. SILVA RH, ABILIO VC, TAKATSU AL et al. Role of hippocampal oxidative stress in memory deficits induced by sleep deprivation in mice. Neuropharmacol 2004;46:895-903.
71. HAIRSTON IS, LITTLE MTM, SCANLON MD et al. Sleep restriction suppresses neurogenesis induced by hippocampus-dependent learning. J Neurophysiol 2005;94:4224-4233.
72. ROMAN V, VAN DER BORGHT K, LEEMBURG SA et al. Sleep restriction by forced activity reduces hippocampal cell proliferation. Brain Res 2005;1065:53-59.
73. CORNER MA, BAKER RE, VAN PELT J. Physiological consequences of selective suppression of synaptic transmission in developing cerebral cortical networks in vitro: differential effects on intrinsically generated bioelectric discharges in a living 'model' system for slow-wave sleep activity. Neurosci Biobehav Rev 2008;32:1569-1600.
74. KRUEGER JM, OBAL F. Sleep function. Front Biosci 2003;8:511-519.
75. GUZMAN-MARIN R, YING Z, SUNTSOVA N et al. Suppression of hippocampal plasticity-related gene expression by sleep deprivation in rats. J Physiol 2006;575:807-819.
76. ROMCY-PEREIRA RN, LEITE JP, GARCIA-CAIRASCO N. Synaptic plasticity along the sleep-wake cycle: implications for epilepsy. Epilepsy Behav 2009;14:47-53.
77. LEPROULT R, COPINSCHI G, BUXTON O et al. Sleep loss results in an elevation of cortisol levels the next evening. Sleep 1997;20:865-870.
78. SPATH-SCHWALBE E, GOFFERJE M, KERN W, BORN J, FEHM HL. Sleep disruption alters nocturnal ACTH and cortisol secretory patterns. Biol Psychiatry 1991;29:575-584.
79. HOFLE N, PAUS T, REUTENS D, FISET P, GOTMAN J, EVANS A. Regional cerebral blood flow changes as a function of delta and spindle activity during slow wave sleep in humans. J Neurosci 1997;17:4800-4808.
80. LOTRICH FE, ALBUSAYSI S, FERRELL RE. Brain-derived neurotrophic factor serum levels and genotype: association with depression during interferon-alpha treatment. Neuropsychopharmacol 2013;38:989-995.
81. KANEKO N, KUDO K, MABUCHI T et al. Suppression of cell proliferation by interferon-alpha through interleukin-1 production in adult rat dentate gyrus. Neuropsychopharmacol 2006;31:2619-2626.
82. BEN MENACHEM-ZIDON O, GOSHEN I, KREISEL T et al. Intrahippocampal transplantation of transgenic neural precursor cells overexpressing interleukin-1 receptor antagonist blocks chronic isolation-induced impairment in memory and neurogenesis. Neuropsychopharmacol 2008;33:2251-2262.
83. BARRIENTOS RM, SPRUNGER DB, CAMPEAU S et al. Brainderived neurotrophic factor mRNA downregulation produced by social isolation is blocked by intrahippocampal interleukin-1 receptor antagonist. Neuroscience 2003;121:847-853.
84. KOO JW, DUMAN RS. IL-1beta is an essential mediator of the antineurogenic and anhedondic effects of stress. PNAS USA 2008;105:751-756.
85. PENG CH, CHIOU SH, CHEN SJ, CHOU YC, K Y HH, CHENG CK. Neuroprotection by imipramine against lipopolysaccharide-induced apoptosis in hippocampusderived neural stem cells mediated by activation of BDNF and the MAPK pathway. Eur Neuropsychopharmacol 2008;18:128-140.
86. RAISON CL, BORISOV AS,WOOLWINE BJ, MASSUNG B, VOGT G, MILLER AH. Interferon-alpha effects on diurnal hypothalamic-pituitary-adrenal axis activity: relationship with proinflammatory cytokines and behavior. Mol Psychiatry 2010;15:535-547.
87. RAISON CL, BORISOV AS, MAJER M, DRAKE D, PAGNONI G, MILLER AH. Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression. Biol Psychiatry 2009;65:296-303.
88. FELGER JC, ALAGBE O, HU F et al. Effects of interferon-alpha on rhesus monkeys: a nonhuman primate model of cytokineinduced depression. Biol Psychiatry 2007;62:1324-1333.
89. HAROON E, WOOLWINE B, CHEN X et al. IFN-alpha-induced cortical and subcortical glutamate changes assessed by magnetic resonance spectroscopy. Neuropsychopharmacol 2014;39:1777-1785.
90. RAISON CL, RYE DB, WOOLWINE BJ et al. Chronic interferon-alpha administration disrupts sleep continuity and depth in patients with hepatitis C: association with fatigue, motor slowing, and increased evening cortisol. Biol Psychiatry 2010;68:942-949.
91. ANTONIJEVIC IA, STEIGER A. Depression-like changes of the sleep-EEG during high dose corticosteroid treatment in patients with multiple sclerosis. Psychoneuroendocrinol 2003;28:780-795.
92. THASE ME, FASICZKA AL, BERMAN SR, SIMONS AD, REYNOLDS CF. Electroencephalographic sleep profiles before and after cognitive behavior therapy of depression. Arch Gen Psychiatry 1998;55:138-144.
93. NISSEN C, FEIGE B, KONIG A, VODERHOLZER U, BERGER M, RIEMANN D. Delta sleep ratio as a predictor of sleep deprivation response in major depression. J Psychiatr Res 2001;35:155-163.
94. KUPFER DJ, FRANK E, MCEACHRAN AB, GROCHOCINSKI VJ, EHLERS CL. EEG sleep correlates of recurrence of depression on active medication. Depression 1993;1:300-308.
95. CERVENA K, DAUVILLIERS Y, ESPA F et al. Effect of cognitive behavioural therapy for insomnia on sleep architecture and sleep EEG power spectra in psychophysiological insomnia. J Sleep Res 2004;13:385-393.
96. SONNTAG A, ROTHE B, GULDNER J, YASSOURIDIS A, HOLSBOER F, STEIGER A. Trimipramine and imipramine exert different effects on the sleep EEG and on nocturnal hormone secretion during treatment of major depression. Depression 1996;4:1-13.
97. CHALON S, PEREIRA A, LAINEY E et al. Comparative effects of duloxetine and desipramine on sleep EEG in healthy subjects. Psychopharmacol (Berl) 2005;177:357-365.
98. SCHITTECATTE M, DUMONT F, MACHOWSKI R, CORNIL C, LAVERGNE F, WILMOTTE J. Effects of mirtazapine on sleep polygraphic variables in major depression. Neuropsychobiol 2002;46:197-201.
99. ARGYROPOULOS SV, WILSON SJ. Sleep disturbances in depression and the effects of antidepressants. Int Rev Psychiatry 2005;17:237-245.
100. JINDAL RD, FRIEDMAN ES, BERMAN SR, FASICZKA AL, HOWLAND RH, THASE ME. Effects of sertraline on sleep architecture in patients with depression. J Clin Psychopharmacol 2003;23:540-548.
101. EHLERS CL, HAVSTAD JW, KUPFER DJ. Estimation of the time course of slow-wave sleep over the night in depressed patients: effects of clomipramine and clinical response. Biol Psychiatry 1996;39 :171-181.
102. FEIGE B, VODERHOLZER U, RIEMANN D, DITTMANN R, HOHAGEN F, BERGER M. Fluoxetine and sleep EEG: effects of a single dose, subchronic treatment, and discontinuation in healthy subjects. Neuropsychopharmacol 2002;26:246-258.
103. PASTERNAK RE, REYNOLDS CF 3RD, HOUCK PR et al. Sleep in bereavement-related depression during and after pharmacotherapy with nortriptyline. J Geriatr Psychiatry Neurol 1994;7:69-73.
104. ARGYROPOULOS SV, HICKS JA, NASH JR et al. Redistribution of slow wave activity of sleep during pharmacological treatment of depression with paroxetine but not with nefazodone. J Sleep Res 2009;18:342-343.
105. MUSSELMAN DL, LAWSON DH, GUMNICK JF et al. Paroxetine for the prevention of depression induced by high-dose interferon alfa. NEJM 2001;344:961-966.
106. NOWELL PD, REYNOLDS CFR, BUYSSE DJ, DEW MA, KUPFER DJ. Paroxetine in the treatment of primary insomnia: preliminary clinical and electroencephalogram sleep data. J Clin Psychiatry 1999;60:89-95.
107. SALVA M-AQ, VANIER B, LAREDO J et al. Major depressive disorder, sleep EEG and agomelatine: an open-label study. Int J Neuropsychopharmacol 2007;10:691-696.
108. QUERA-SALVA MA, LEMOINE P, GUILLEMINAULT C. Impact of the novel antidepressant agomelatine on disturbed sleepwake cycles in depressed patients. Hum Psychopharmacol 2010;25:222-229.
109. KLUGE M, GAZEA M, SCHUSSLER P et al. Ghrelin increases slow wave sleep and stage 2 sleep and decreases stage 1 sleep and REM sleep in elderly men but does not affect sleep in elderly women. Psychoneuroendocrinol 2010;35:297-304.
110. LOTRICH FE. Inflammatory cytokine-associated depression. Brain Res 2014; epub 10.1016/j.brainres.2014.06.032.
111. FORD DE, KAMEROW DB. Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA 1989;262:1479-1484.